Adams Street Partners
Adams Street Partners operates as a global private market investment management firm.
Business Model:
Revenue: $10M
Employees: 201-500
Rankings
Detailed Adams Street Partners Information
Geographic Data
Address: 1 N Wacker Dr
City: Chicago
State: IL
Zip: 60606
Country: US
Financial Info
Stage:
Raised Last:
$0
Raised Total:$6B
Social
Facebook
Linkedin
Crunchbase
Metrics
2,239,931Website Global Rank
8,559Website Monthly Traffic
Twitter Followers
Description
Adams Street Partners is a global private market investment management firm that offers comprehensive solutions for its investors. As one of the independent, employee-owned firms, Adams Street has established a reputation for strong performance, an extensive knowledge base, and a disciplined investment approach that values quality over quantity. For more than 45 years, Adams Street has gained the experience to successfully manage through some of the most challenging investment cycles. The collective knowledge of the Adams Street team works collaboratively to leverage the global resources of the Firm in navigating the complexities of private markets. Its mission as a premier private markets investment manager is to provide world-class investment performance and maintain the confidence of our investors through our deep understanding of the global private marketplace and deliver exemplary client service.
Contact Phone:
+13125537890
Contact Email:
| Announced Date | Company | Transaction | Money Raised |
|---|---|---|---|
| 8/2003 | comScore | Series E | 12M |
| 11/2017 | Outpost Medicine, LLC | Series A | 20M |
| 1/2012 | Neuraltus Pharmaceuticals | Series B | 9.6M |
| 12/2015 | CBANC | Series B | 4M |
| 1/2011 | PneumRx | Venture Round | 0 |
| 4/2021 | Mineralys Therapeutics | Series A | 0 |
| 3/2011 | RadiumOne | Series B | 31.5M |
| 12/2016 | Tripping.com | Series C | 0 |
| 5/2013 | Atlantis Computing | Series D | 0 |
| 12/2005 | GlobeImmune | Series B | 34.3M |
| 6/2015 | RadiumOne | Series C | 54M |
| 1/2019 | Millennium Trust Co | Venture Round | - |
| 8/2013 | Couchbase | Series D | 25M |
| 12/2012 | Naurex | Series B | 0 |
| 4/2019 | Fusion Pharmaceuticals | Series B | 0 |
| 5/2017 | Smule | Series H | 54M |
| 5/2010 | Arroweye Solutions | Private Equity Round | 8.4M |
| 5/2019 | Solera Health | Series C | 0 |
| 6/2016 | Smule | Series G | 0 |
| 10/2006 | Enfora | Venture Round | 19M |
| 11/2009 | Zynga | Venture Round | - |
| 9/2009 | RadiumOne | Series A | 2M |
| 12/2017 | Aptinyx | Series B | 70M |
| 8/2003 | Engim | Series B | 18.5M |
| 3/2016 | Maxwell Health | Series C | 0 |
| 12/2014 | Maxwell Health | Series B | 26.4M |
| 3/2007 | PneumRx | Series B | 0 |
| 10/2021 | Orca Security | Series C | 0 |
| 5/2007 | Convio | Series E | 10.2M |
| 5/2003 | SPS Commerce | Venture Round | 18M |
| 2/2010 | BrightRoll | Series C | 10M |
| 7/2004 | Convio | Series D | 15M |
| 2/2021 | Redox | Series D | 45M |
| 1/2006 | MX Logic | Series E | 6.5M |
| 12/2007 | MX Logic | Series G | 2.7M |
| 11/2008 | MX Logic | Series G | 5.7M |
| 4/2008 | Visible World | Series C | 25M |
| 9/2015 | Corvus Pharmaceuticals | Series B | 75M |
| 11/2008 | Arroweye Solutions | Private Equity Round | 23.5M |
| 4/2012 | Five9 | Venture Round | 12M |
| 11/2016 | TrendKite | Series D | 16.3M |
| 3/2014 | ThreatMetrix | Series E | 20M |
| 11/2008 | OncoMed Pharmaceuticals | Series B | 154M |
| 8/2014 | Scytl | Series C | 44M |
| 10/2018 | Arctic Wolf | Series C | 45M |
| 6/2021 | Aircall | Series D | 0 |
| 5/2020 | Aircall | Series C | 0 |
| 11/2011 | Rempex Pharmaceuticals | Series B | 67.5M |
| 9/2014 | BoomTown | Series A | 20.1M |
| 2/2008 | Snagajob | Series B | 5M |
| 1/2011 | Five9 | Series C | 8.6M |
| 7/2002 | Sensys Medical | Series D | 0 |
| 6/2015 | Chrome River Technologies | Series D | 100M |
| 2/2019 | PerimeterX | Series C | 43M |
| 11/2011 | Pivot Medical | Series C | 32M |
| 12/2014 | Naurex | Series C | 0 |
| 5/2007 | Arroweye Solutions | Series C | 14M |
| 10/2007 | TriReme Medical | Series C | 15.5M |
| 5/2021 | Homeward | Series B | 136M |
| 5/2020 | Homeward | Series A | 20M |
| 7/2011 | Adesto Technologies | Series C | 17.4M |
| 8/2015 | Apto | Series B | 8M |
| 3/2017 | TurnKey Vacation Rentals | Series C | 21M |
| 3/2018 | TurnKey Vacation Rentals | Series D | 31M |
| 4/2017 | Cirius Therapeutics | Series A | 0 |
| 12/2017 | Atox Bio | Series F | 0 |
| 2/2018 | Cofense | Venture Round | - |
| 9/2019 | PerimeterX | Series C | 0 |
| 2/2005 | Aesthera Corporation | Series B | 6.5M |
| 7/2006 | Snagajob | Series A | 9M |
| 6/2014 | Visier | Series C | 25.5M |
| 6/2017 | MyHealthTeams | Series A | 7.3M |
| 6/2022 | Mineralys Therapeutics | Series B | 0 |
| 6/2012 | LogRhythm | Series D | 15M |
| 3/2003 | Livevault | Series B | 10M |
| 3/2011 | LogRhythm | Series C | 10M |
| 12/2019 | Epirium Bio | Series A | 0 |
| 5/2004 | PathScale | Series C | 15M |
| 9/2021 | Nomad Health | Series D | 0 |
| 9/2004 | MX Logic | Series D | 8M |
| 1/2012 | Donuts | Series A | 0 |
| 9/2009 | Actelis Networks | Venture Round | 0 |
| 1/2007 | FarmLink | Venture Round | 0 |
| 5/2012 | Cybera | Venture Round | 4.4M |
| 8/2001 | comScore | Series C | 15M |
| 2/2019 | GoCardless | Series E | 75M |
| 3/2016 | Outpost Medicine | Series A | 41M |
| 2/2017 | Scytl | Series D | 13M |
| 11/2019 | Punchh | Series C | 40M |
| 2/2002 | Livevault | Venture Round | 8M |
| 7/2017 | Lever | Series C | 40M |
| 8/2018 | Cirius Therapeutics | Series A | 9M |
| 2/2014 | MyHealthTeams | Series A | 3.4M |
| 8/2021 | Hopin | Series D | 0 |
| 9/2003 | Quallaby Corporation | Series E | 5M |
| 11/2022 | DispatchHealth | Series E | 330M |
| 4/2014 | Boundary | Series C | 22M |
| 8/2012 | MyHealthTeams | Seed Round | 1.8M |
| 2/2009 | Mpex Pharmaceuticals | Series D | 27.5M |
| 4/2022 | Reify Health | Series D | 220M |
| 3/2017 | Visier | Series D | 0 |
| 11/2015 | Earnest | Series B | 75M |
| 3/2013 | Q2ebanking | Series C | 20M |
| 2/2006 | Cybera | Venture Round | 12.8M |
| 11/2016 | CareCloud Corporation | Series C | 31.5M |
| 9/2017 | Fusion Pharmaceuticals | Series A | 0 |
| 4/2021 | ThreatQuotient | Debt Financing | 0 |
| 1/2022 | Dremio | Series E | 0 |
| 1/2016 | healthfinch | Series A | 7.5M |
| 2/2021 | PerimeterX | Series D | 0 |
| 10/2005 | Light Sciences Oncology | Series A | 35M |
| 2/2018 | Dynamic Signal | Series E | 0 |
| 7/2004 | Danger | Series D | 37M |
| 6/2010 | Adesto Technologies | Venture Round | 3.5M |
| 1/2004 | E4 X Inc | Series C | 0 |
| 7/2012 | Borderfree | Series E | 0 |
| 5/2011 | Naurex | Series A | 18M |
| 6/2022 | Nomad Health | Venture Round | 0 |
| 12/2010 | RetailMeNot | Series B | 90M |
| 8/2010 | YouSendIt | Series D | 15M |
| 11/2013 | Hightail | Series E | 0 |
| 1/2018 | MATRIXX Software | Series C | 0 |
| 4/2014 | Damballa | Series E | 13M |
| 11/2017 | ThreatQuotient | Series C | 30M |
| 3/2022 | BillionToOne | Series C | 0 |
| 8/2001 | Myogen | Series D | 52.4M |
| 8/2019 | MyHealthTeams | Series B | 0 |
| 11/2015 | MyHealthTeams | Series A | 5M |
| 3/2011 | Snagajob | Series C | 27M |
| 4/2021 | Icosavax | Series B | 0 |
| 9/2012 | Criteo | Series D | 40M |
| 4/2015 | Smule | Series F | 26M |
| 6/2021 | Visier | Series E | 125M |
| 8/2018 | Millendo Therapeutics | Venture Round | 30M |
| 1/2016 | Millendo Therapeutics | Series B | 0 |
| 6/2002 | comScore | Series D | 20M |
| 4/2010 | Amonix | Series B | 0 |
| 6/2010 | Incline Therapeutics | Series A | 43M |
| 4/2022 | Remote | Series C | 0 |
| 11/2007 | RadPharm | Series B | 10M |
| 6/2021 | Iterable | Series E | 0 |
| 3/2009 | Neuraltus Pharmaceuticals | Series A | 17M |
| 11/2016 | Sauce Labs | Venture Round | 70M |
| 2/2010 | WebVisible | Series C | 20M |
| 1/2015 | Yeahka | Venture Round | - |
| 8/2005 | Mpex Pharmaceuticals | Series B | 0 |
| 1/2004 | Aesthera Corporation | Series A | 2.5M |
| 11/2012 | ServiceMax | Series D | 27M |
| 7/2017 | Solera Health | Series B | 18.3M |
| 8/2005 | Stratavia | Series A | 3.3M |
| 7/2007 | Stratavia | Series B | 6.3M |
| 11/2014 | Bluprint | Series D | 50M |
| 10/2011 | MATRIXX Software | Series B | 12M |
| 1/2002 | CBeyond | Venture Round | - |
| 9/2015 | Cybera | Private Equity Round | - |
| 8/2016 | LogRhythm | Venture Round | 50M |
| 8/2013 | CareCloud Corporation | Series B | 9M |
| 6/2001 | SPS Commerce | Series D | 10M |
| 1/2017 | Included Health (previously Grand Rounds Health and Doctor On Demand) | Venture Round | - |
| 5/2009 | Peerless Network | Venture Round | 10.1M |
| 10/2019 | Icosavax | Series A | 0 |
| 4/2012 | Neuraltus Pharmaceuticals | Venture Round | 0 |
| 1/2010 | magicJack | Venture Round | - |
| 5/2007 | ShermansTravel Media, LLC | Private Equity Round | 14M |
| 5/2013 | Five9 | Series D | 22M |
| 3/2006 | RadPharm | Series A | 8M |
| 5/2009 | Revascular Therapeutics | Series B | 3M |
| 5/2017 | Snow Software | Venture Round | - |
| 1/2016 | Skybox Security | Venture Round | - |
| 1/2018 | Therapy Brands | Venture Round | - |
| 8/2015 | Orbus Therapeutics | Series A | 32.5M |
| 5/2008 | Paylocity | Venture Round | 10M |
| 12/2013 | Bluprint | Series C | 35M |
| 3/2007 | WhiteFence | Series B | 0 |
| 12/2005 | Light Sciences Oncology | Series A | 32M |
| 2/2018 | Partner Therapeutics | Series A | 60M |
| 5/2019 | SymphonyRM | Series A | 10M |
| 1/2007 | DolEx Dollar Express | Venture Round | - |
| 7/2011 | Jaspersoft | Unattributed | 11M |
| 2/2006 | Aesthera Corporation | Series C | 11M |
| 6/2009 | Integral Development Corp | Venture Round | 11M |
| 11/2006 | MX Logic | Series F | 4M |
| 7/2019 | TurnKey Vacation Rentals | Series E | 48M |
| 4/2011 | Spiceworks, Inc. | Series D | 25M |
| 1/2007 | Actelis Networks | Series E | 22M |
| 10/2013 | Mintigo | Series C | 10M |
| 2/2014 | Spiceworks, Inc. | Series E | 57M |
| 6/2007 | WiQuest Communications | Series C | 28M |
| 9/2008 | Sportgenic | Series B | 10M |
| 4/2007 | Cybera | Series C | 18M |
| 9/2012 | Damballa | Series E | 15M |
| 3/2021 | Advise Health | Series A | 100M |
| 11/2011 | BrightRoll | Series D | 20.3M |
| 5/2017 | Mintigo | Series E | 0 |
| 6/2014 | Couchbase | Series E | 60M |
| 3/2016 | Couchbase | Series F | 30M |
| 7/2022 | ClassDojo | Series D | 125M |
| 9/2019 | VillageMD | Series B | 100M |
| 5/2021 | SymphonyRM | Series B | 0 |
| 5/2020 | Palvella Therapeutics | Series C | 0 |
| 12/2006 | Setanta | Private Equity Round | 0 |
| 5/2016 | Aptinyx | Series A | 0 |
| 1/2007 | Ancestry | Funding Round | - |
| 7/2014 | LogRhythm | Series E | 40M |
| 9/2010 | Solaria | Series D | 65M |
| 8/2007 | Luminary Micro | Series C | 25M |
| 8/2013 | CareCloud | Series B | 9M |
| 4/2021 | ThreatQuotient | Venture Round | 0 |
| 3/2004 | Jazz Pharmaceuticals | Series B | 0 |
| 11/2016 | CareCloud | Post-IPO Equity | 0 |
| 6/2001 | Quallaby Corporation | Venture Round | 14.5M |
| 1/1999 | Syneos Health | Venture Round | - |
| 1/2004 | Borderfree | Series C | 13.8M |
| 10/2010 | TriReme Medical | Series D | 17M |
| 4/2023 | Altruist | Series D | 0 |
| 6/2004 | Proteus Digital Health | Series B | 6.3M |
| 12/2022 | BillionToOne | Series C | 0 |
| 8/2021 | Reify Health | Series C | 220M |
| 1/2002 | Synchronoss Technologies | Series A | 0 |
| 5/2001 | Synchronoss Technologies | Series A | 0 |
| 4/2014 | Telesign | Series B | 40M |
| 5/2020 | Couchbase | Series G | 0 |
| 1/2007 | TicketsNow | Series A | 34M |
| 6/2022 | FalconX | Series D | 0 |
| 12/2008 | Jaspersoft | Venture Round | 12.5M |
| 10/2018 | Qpex Biopharma | Series A | 33M |
| 5/2001 | Netcontinuum | Series B | 26M |
| 7/2020 | Robinhood | Series F | 0 |
| 7/2022 | ClassDojo | Series D | 0 |
| 6/2022 | Nomad Health | Venture Round | 0 |
| 6/2022 | FalconX | Series D | 0 |
| 6/2022 | Mineralys Therapeutics | Series B | 0 |
| 4/2022 | Reify Health | Series D | 0 |
| 4/2022 | Remote | Series C | 0 |
| 3/2022 | BillionToOne | Series C | 0 |
| 1/2022 | Dremio | Series E | 0 |
| 10/2021 | Orca Security | Series C | 0 |
| 9/2021 | Nomad Health | Series D | 0 |
Startup Industries
Startup Locations
Portfolio Current Status
Portfolio Employee Count
| Name | Price |
|---|
| Name | Size | Announced Date |
|---|
